Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

Cancer

Volumn 79, Issue 10, 1997, Pages 1969-1976

  Gohji, Kazuo ^a,c   Nomi, Masashi ^a   Egawa, Shin ^b   Morisue, Koichi ^a   Takenaka, Atsushi ^a   Okamoto, Masayuki ^a   Ohori, Makoto ^b   Fujii, Akio ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY   (Japan)

Author keywords

Japanese men; prostate carcinoma; prostate specific antigen; prostate specific antigen density; transition zone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; HISTOPATHOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FORECASTING; HUMANS; JAPAN; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; RECTUM; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0030918533     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1969::AID-CNCR19>3.0.CO;2-T     Document Type: Article

References (22)

1. Wingo P, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995;45:12.
2. Tominaga S, Aoki K, Hanai A, Kurihara N, editors. Cancer statistics-incidence/mortality/prognosis, 1993. Tokyo: Shinohara Publishing Co., 1993:154-70.
3. Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, et al. Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project. J Urol 1994;152:1737-40.
4. Mettlin C, Lee F, Drago J, Murphy GP, the investigators of the American Cancer Society National Prostate Cancer Detection Project. The American Cancer Society National Prostate Cancer Detection Project: findings on the detection of early prostate cancer in 2,425 men. Cancer 1991;67:2949-58.
5. Lee F, Torp-Pedersen ST, Littrup PJ, McLeary RD, McHugh TA, Smid AP, et al. Hypoechoic lesion of the prostate: clinical relevance of prostate-specific antigen. Radiology 1989; 190:29-32.
6. Cooner WH, Mosley BR, Rutherford CL Jr., Beard JN, Pond HS, Rerry WJ, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146-54.
7. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
8. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
9. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6.
10. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-21.
11. McNeal JE. The prostate gland: morphology and pathobiology. Mongr Urol 1988;9:36-54.
12. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSADT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1993;43:601-6.
13. Egawa S, Suyama K, Ohori M, Kawakami T, Kuwao S, Hirokado K, et al. Early detection of prostate cancer. Results of a prostate specific antigen based detection program in Japan. Cancer 1995;76:463-72.
14. Egawa S, Koh H, Satoh T, Ohori M, Uchida T, Kuwao S, et al. Preoperative serum prostate-specific antigen, clinical stage and gleason sum as basis for predicting final pathological stage in Japanese prostate cancer. Jpn J Clin Oncol 1996;26:438-44.
15. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-7.
16. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-5.
17. Bostwick DG. High grade prostatic intraepithelial neoplasia, the most likely precursor of prostate cancer. Cancer 1995;75:1823-36.
18. Stamey TA, Kabalin JN, McNeal JN, Johnstone IM, Freiha F, Redwine EA, et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II Radical prostatectomy treated patients. J Urol 1989;141:1076-83.
19. Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;151:88-93.
20. Catalona WJ, Richie JP, Dekernion JB, Ahmann FR, Rarliff TL, Dalkin BL, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristics curves. J Urol 1994;152:2031-6.
21. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995;75:347-53.
22. Babaian RJ, Kojima M, Ramirez EI, Johnston D. Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer. J Urol 1996;156:432-7.